Description: Dr. Racke explains the evolution of cancer therapy towards more targeted approaches, illustrates how a patient’s genetic makeup can influence cancer treatment strategies and outcomes, and describes how companion diagnostics are utilized to help identify patients who may respond to targeted therapies.
•	Illustrate how a patient’s genetic makeup can influence cancer treatment strategies and outcomes.
ASCLS P.A.C.E.® credits are available to laboratory professionals through January 26, 2017.